Abbott Laboratories, an Illinois-based healthcare company that manufactures and sells infant formula and nutritional therapy products, has agreed to pay $384,999,040 to resolve allegations under the False Claims Act (FCA) concerning products manufactured at its facilities in Sturgis, Michigan, and Casa Grande, Arizona.
The allegations relate to products supplied to federal and state programs between January 1, 2018, and December 31, 2022. The United States alleged that Abbott caused government programs to purchase powdered infant formula and nutritional therapy products that did not comply with applicable statutory, regulatory, and contractual requirements.
On November 13, 2025, the United States filed a Complaint in Intervention alleging that Abbott caused government programs to purchase powdered infant formula manufactured at its Sturgis facility despite its alleged failure to meet applicable requirements. The civil settlement resolves these allegations.
| Category | Details |
|---|---|
| Company | Abbott Laboratories |
| Headquarters | Illinois, United States |
| Industry | Healthcare, infant formula and nutritional products |
| Total settlement | $384,999,040 |
| Federal settlement | $348,700,868 |
| State settlement | $36,298,172 |
| Relevant period | January 1, 2018–December 31, 2022 |
| Facilities identified | Sturgis, Michigan, and Casa Grande, Arizona |
| Legal framework | False Claims Act |
| Complaint in Intervention | Filed November 13, 2025 |
| Court | U.S. District Court for... |
US Secretary of State Marco Rubio has sharply rejected Volodymyr Zelensky’s claims that Washington has slowed intelligence and battlefield support to Ukraine, insisting there has been no pause in ...